Dabigatran may be a cost-effective alternative to warfarin for stroke prevention in atrial fibrillation

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2011年 / 46卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：39 / 39
页数：1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS ANALYSIS COMPARING DABIGATRAN AND ADJUSTED-DOSE WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION
    Zhao, Y.
    Lim, L.
    Coleman, C., I
    VALUE IN HEALTH, 2011, 14 (03) : A41 - A41
  • [22] COST-EFFECTIVENESS OF EDOXABAN, APIXABAN, RIVAROXABAN AND DABIGATRAN VERSUS WARFARIN FOR STROKE PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
    Marchetti, M.
    Liberato, N. L.
    Rognoni, C.
    Quaglini, S.
    HAEMATOLOGICA, 2014, 99 : 487 - 487
  • [23] COST-EFFECTIVENESS OF DABIGATRAN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION IN CHINA
    Wan, Y.
    Davies, G. M.
    Lu, Z. G.
    Chen, F.
    Chen, J.
    VALUE IN HEALTH, 2014, 17 (03) : A114 - A114
  • [24] Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland
    Pletscher, Mark
    Plessow, Rafael
    Eichler, Klaus
    Wieser, Simon
    SWISS MEDICAL WEEKLY, 2013, 143
  • [25] Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack
    Kamel, Hooman
    Johnston, S. Claiborne
    Easton, J. Donald
    Kim, Anthony S.
    STROKE, 2012, 43 (03) : 881 - +
  • [26] Newer Diagnostic and Cost-Effective Ways to Identify Asymptomatic Atrial Fibrillation for the Prevention of Stroke
    Patel, Urvish K.
    Malik, Preeti
    Patel, Nidhi
    Patel, Priyadarshee
    Mehta, Neev
    Urhoghide, Eseosa
    Aedma, Surya
    Chakinala, Raja Chandra
    Shah, Shamik
    Arumaithurai, Kogulavadanan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (01)
  • [27] Self-management of Vitamin K Antagonists Is More Cost-effective Than Dabigatran for Stroke Prevention in Nonvalvular Atrial Fibrillation in Spain
    Souto, Juan C.
    Ruyra, Xavier
    Bayes-Genis, Antoni
    REVISTA ESPANOLA DE CARDIOLOGIA, 2013, 66 (06): : 510 - 511
  • [28] Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study
    Larsen, Torben Bjerregaard
    Rasmussen, Lars Hvilsted
    Gorst-Rasmussen, Anders
    Skjoth, Flemming
    Lane, Deirdre A.
    Lip, Gregory Y. H.
    AMERICAN JOURNAL OF MEDICINE, 2014, 127 (12): : 1172 - +
  • [29] Dabigatran for the prevention of stroke in patients with atrial fibrillation
    Diener, Hans-Christoph
    Weber, Ralph
    Weimar, Christian
    Frank, Benedikt
    Kirchhof, Paulus
    PSYCHOPHARMAKOTHERAPIE, 2011, 18 (04): : 156 - +
  • [30] Is dabigatran cost-effective compared with warfarin in patients with AF?
    Alexandra King
    Nature Reviews Cardiology, 2012, 9 (1) : 3 - 3
12345